Ruipeng Song
State Key Laboratory Of Immune Response And Immunotherapy
Hefei, 230001, China
Hefei, 230001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
G4 DNA potentiates KDM2B phase separation to couple transcriptional repression with immune remodeling in hepatocellular carcinoma.
Journal: Cancer letters
Published: January 24, 2026
Standardized Management Pathway to Prevent Acute Rejection After Liver Transplantation Following ICI Therapy for Downstaging HCC.
Journal: Health care science
Published: November 06, 2025
Author Correction: RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma.
Journal: Nature cancer
Published: August 04, 2025
Laparoscopic resection combined with ablation for multiple colorectal liver metastases: a multicentre propensity-matched analysis.
Journal: Surgical endoscopy
Published: March 12, 2025
A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma.
Journal: NPJ precision oncology
Published: December 31, 2024
Predicting Immunotherapy Response in Unresectable Hepatocellular Carcinoma: A Comparative Study of Large Language Models and Human Experts.
Journal: Journal of medical systems
Published: December 15, 2024
Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant.
Journal: Journal of hepatocellular carcinoma
Published: September 22, 2024
Comparison of 2 Different Types of Arterial and Biliary Anastomoses While Preserving the Gastroduodenal Artery: A Retrospective Study.
Journal: Transplantation proceedings
Published: June 11, 2024
Enhanced recovery after liver transplantation-a prospective analysis focusing on quality assessment.
Enhanced recovery after liver transplantation-a prospective analysis focusing on quality assessment.
Journal: Hepatobiliary surgery and nutrition
Published: April 01, 2024
Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience.
Journal: Therapeutic advances in medical oncology
Published: December 22, 2023
Last Updated: 09/26/2026